GENERIC NAME OF THE MEDICINAL PRODUCT:

Deferasirox Dispersible Tablets 100mg (DEFRATAJ)
Deferasirox Dispersible Tablets 125mg (DEFRATAJ)
Deferasirox Dispersible Tablets 250mg (DEFRATAJ)
Deferasirox Dispersible Tablets 400mg (DEFRATAJ)
Deferasirox Dispersible Tablets 500mg (DEFRATAJ)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

a) Deferasirox Dispersible Tablets 100mg
Each uncoated dispersible tablet contains:
Deferasirox……………………….100mg
Exipients……………………………q.s.

b) Deferasirox Dispersible Tablets 125mg
Each uncoated dispersible tablet contains:
Deferasirox……………………….125mg
Exipients……………………………q.s.

c) Deferasirox Dispersible Tablets 250mg
Each uncoated dispersible tablet contains:
Deferasirox……………………….250mg
Exipients……………………………q.s.

d) Deferasirox Dispersible Tablets 400mg
Each uncoated dispersible tablet contains:
Deferasirox……………………….400mg
Exipients……………………………q.s.

e) Deferasirox Dispersible Tablets 500mg
Each uncoated dispersible tablet contains:
Deferasirox……………………….500mg
Exipients……………………………q.s.


THERAPEUTIC INDICATIONS:

Deferasirox is used to remove excess iron from the body in patients who have had too many blood transfusions and in patients with non-transfusion dependent thalassemia syndromes. Deferasirox is an iron chelator (binder). it combines with iron in the blood.

CAUTION & SCHEDULE:

CAUTION:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
DO NOT CHEW OR SWALLOW WHOLE.
Take this medicine on an empty stomach.
Dispense tablet in water before consuming.
Take Defrataj once daily on an empty stomach at least 30 minutes before food, preferably at the same time each day. Completely disperse tablet by stirring in water until a fine suspension obtained. SCHEDULE “H” Prescription Drug : Not to be sold by retail without the prescription of a Registered Medical Prescriber.

STORAGE & DOSAGE:

Storage: Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.
Dosage: As directed by the Physician.

Deferasirox Dispersible Tablets 500mg Technical Specification:

Product Name:               Deferasirox Dispersible Tablets IP
Brand Name: DEFRATAJ
Strength: 100mg, 125mg, 250mg, 400mg, 500mg
Dosage Form: Tablets (Dispersible uncoated tablet)
Route of Administration: Via oral Route
Packing: 30s, 90s, 100s, 500s, 1000s
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Iron Chelator, Paediatrics, Metabolism
Indication: This medication is used to treat ongoing high levels of iron in the body caused by multiple blood transfusions. It is also used to treat high levels of iron in people with a certain blood disorder who do not require blood transfusions
Storage: Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Deferasirox Dispersible Tablets IP100mg
  • Deferasirox Dispersible Tablets IP125mg
  • Deferasirox Dispersible Tablets IP 250mg
  • Deferasirox Dispersible Tablets IP 400mg
  • Deferasirox Dispersible Tablets IP 500mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • a) Deferasirox Dispersible Tablets 100mg
    Each uncoated dispersible tablet contains:
    Deferasirox……………………….100mg
    Exipients……………………………q.s.
  • b) Deferasirox Dispersible Tablets 125mg
    Each uncoated dispersible tablet contains:
    Deferasirox……………………….125mg
    Exipients……………………………q.s.
  • c) Deferasirox Dispersible Tablets 250mg
    Each uncoated dispersible tablet contains:
    Deferasirox……………………….250mg
    Exipients……………………………q.s.
  • d) Deferasirox Dispersible Tablets 400mg
    Each uncoated dispersible tablet contains:
    Deferasirox……………………….400mg
    Exipients……………………………q.s.
  • e) Deferasirox Dispersible Tablets 500mg
    Each uncoated dispersible tablet contains:
    Deferasirox……………………….500mg
    Exipients……………………………q.s.

THERAPEUTIC INDICATIONS:

  • Deferasirox is used to remove excess iron from the body in patients who have had too many blood transfusions and in patients with non-transfusion dependent thalassemia syndromes. Deferasirox is an iron chelator (binder). it combines with iron in the blood.

CAUTION & SCHEDULE:

  • CAUTION:
    Read enclosed leaflet before use.
    Keep medicine out of reach of children.
    DO NOT CHEW OR SWALLOW WHOLE.
    Take this medicine on an empty stomach.
    Dispense tablet in water before consuming.
    Take Defrataj once daily on an empty stomach at least 30 minutes before food, preferably at the same time each day. Completely disperse tablet by stirring in water until a fine suspension obtained.
  • SCHEDULE “H” Prescription Drug : Not to be sold by retail without the prescription of a Registered Medical Prescriber.

STORAGE & DOSAGE:

  • Storage:  Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.
  • Dosage:  As directed by the Physician.

Deferasirox Dispersible Tablets 500mg – Leading PAN India Manufacturer & Supplier

Introduction to Deferasirox Dispersible Tablets 500mg

Deferasirox dispersible tablets 500mg are a widely used iron chelator medication designed to treat chronic iron overload in patients with transfusion-dependent and non-transfusion-dependent thalassemia syndromes. Manufactured by Taj Pharmaceuticals, one of India’s leading pharmaceutical companies, Deferasirox helps eliminate excess iron, ensuring better health and improved quality of life for patients undergoing frequent blood transfusions.

Taj Pharmaceuticals is a top-tier manufacturer, exporter, and supplier of Deferasirox dispersible tablets 500mg, serving clients across India, Africa, the Middle East, and Latin America (LTAM) with high-quality pharmaceutical solutions.


Understanding Deferasirox: Mechanism of Action

Deferasirox dispersible tablets 500mg function as an oral iron chelator, binding to excess iron in the bloodstream and forming a complex that is excreted through stool. This helps prevent iron accumulation in vital organs like the liver, heart, and pancreas, reducing the risk of iron toxicity and associated complications.

Iron overload is a significant concern in patients receiving frequent blood transfusions, as excess iron from transfused red blood cells can cause severe organ damage. Deferasirox plays a crucial role in maintaining iron balance in the body.


High-Quality Deferasirox Dispersible Tablets by Taj Pharmaceuticals

Taj Pharmaceuticals, based in Vapi, Gujarat, India, is a renowned manufacturer and supplier of Deferasirox dispersible tablets 500mg. Our state-of-the-art manufacturing facility adheres to strict quality control measures, ensuring that our products meet international pharmaceutical standards.

Why Choose Taj Pharmaceuticals?

Premium-Quality Manufacturing: We follow Good Manufacturing Practices (GMP) and comply with stringent international regulations.
PAN India Supplier & Exporter: Trusted by healthcare professionals and distributors across India, Africa, the Middle East, and LTAM.
Regulatory Compliance: We adhere to global regulatory requirements, ensuring the highest safety and efficacy standards.
Affordable Pricing: Our competitive pricing structure makes Deferasirox accessible to patients worldwide.
Reliable Supply Chain: We guarantee a steady supply of Deferasirox dispersible tablets 500mg for bulk buyers and distributors.


Therapeutic Uses of Deferasirox Dispersible Tablets 500mg

Deferasirox is a lifesaving medication used in various medical conditions related to iron overload. Some of the primary indications include:

  • Chronic Iron Overload in Transfusion-Dependent Patients: Individuals with thalassemia major, sickle cell disease, and other chronic anemias often require regular blood transfusions, leading to excess iron accumulation. Deferasirox helps manage and prevent iron toxicity.

  • Iron Overload in Non-Transfusion-Dependent Thalassemia Syndromes: Patients with hereditary or genetic conditions may develop iron overload without transfusions. Deferasirox aids in iron excretion and prevents organ damage.

  • Iron Overload in Myelodysplastic Syndromes (MDS): Patients undergoing frequent transfusions due to bone marrow disorders benefit significantly from Deferasirox therapy.


How to Use Deferasirox Dispersible Tablets 500mg

Dosage and Administration

Deferasirox dispersible tablets should be taken as per the doctor’s prescription. The typical dosage depends on the patient’s weight, iron levels, and underlying condition.

Take on an Empty Stomach: For best results, consume Deferasirox at least 30 minutes before a meal.
Dissolve in Water: The dispersible tablet should be completely dissolved in a glass of water before consumption.
Consistent Daily Intake: It is crucial to take the medication at the same time every day to maintain steady drug levels in the body.

Important: Always follow your healthcare provider’s instructions regarding dosage adjustments based on periodic blood tests.


Precautions and Safety Information

Deferasirox dispersible tablets 500mg are a potent medication and should be used with caution. Patients must be aware of potential side effects and safety precautions.

Who Should Not Take Deferasirox?

  • Pregnant or Breastfeeding Women: The safety of Deferasirox during pregnancy is not well established. It is advised to consult a doctor before use.

  • Patients with Severe Kidney or Liver Disorders: Deferasirox is metabolized in the liver and excreted through stool; hence, individuals with impaired liver or kidney function should seek medical advice.

  • Individuals with Known Allergies: Those allergic to Deferasirox or its excipients should avoid this medication.

Potential Side Effects

Although generally well-tolerated, some patients may experience:

  • Gastrointestinal Disturbances: Nausea, vomiting, diarrhea, or abdominal pain.

  • Skin Rashes or Allergic Reactions: Discontinue use and seek medical help if severe reactions occur.

  • Elevated Liver Enzymes: Regular liver function tests are essential during treatment.

  • Hearing or Vision Problems: Rare cases of hearing loss or blurred vision have been reported.

Patients should immediately report any unusual symptoms to their healthcare provider.


Global Reach of Taj Pharmaceuticals – Leading Supplier & Exporter

Taj Pharmaceuticals has established itself as a trusted global supplier of Deferasirox dispersible tablets 500mg, catering to pharmaceutical distributors, hospitals, and healthcare providers worldwide.

Our Distribution Network Covers:

India: PAN India supplier, including Mumbai, Gujarat, Delhi, Chennai, and Kolkata.
Africa: Exporting to Nigeria, Kenya, South Africa, Egypt, and Ghana.
Middle East: Supplying countries like UAE, Saudi Arabia, Oman, and Qatar.
Latin America (LTAM): Exporting to Brazil, Mexico, Colombia, and Argentina.

Our strong logistics and distribution channels ensure that bulk orders are processed efficiently and delivered on time.


Bulk Supply & PCD Pharma Franchise for Deferasirox Dispersible Tablets

Taj Pharmaceuticals offers PCD Pharma Franchise opportunities for distributors and healthcare professionals looking to expand their business in the iron chelation therapy sector.

Why Partner with Us?

  • Exclusive Monopoly Rights in Your Territory

  • Marketing & Promotional Support

  • High-Profit Margins on Sales

  • Timely Supply & Stock Availability

For bulk orders or franchise inquiries, contact our sales team today.


Trusted Deferasirox Manufacturer in India

Taj Pharmaceuticals is a leading manufacturer, exporter, and supplier of Deferasirox dispersible tablets 500mg, ensuring world-class quality, regulatory compliance, and affordability. Our commitment to excellence makes us the preferred choice for healthcare professionals, pharmaceutical distributors, and patients worldwide.

For premium-quality Deferasirox dispersible tablets 500mg, bulk supply inquiries, or PCD Pharma Franchise opportunities, contact Taj Pharmaceuticals today.